首页工具

登录

搜索结果

Search Results for " aurora-a kinase "

52

抑制剂 & 化合物

1

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T9040	Aurora kinase inhibitor-2 IUN-70219,Aurora Kinase Inhibitor II	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Aurora kinase inhibitor-2 (IUN-70219) 是一种可渗透细胞的苯胺喹唑啉，可抑制极光激酶的活性，对Aurora A 和Aurora B 的IC50分别为 390 nM 和 240 nM。
T6767	TCS7010 Aurora A Inhibitor I	Apoptosis; Aurora Kinase	Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic
	TCS7010 (Aurora A Inhibitor I) 是一种选择性的 Aurora A 抑制剂，IC50值为 3.4 nM。
T21981	Phthalazinone pyrazole	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Phthalazinone pyrazole 是强效、选择性和口服生物可利用的 Aurora-A 激酶抑制剂，IC50值为 0.031 μM。它抑制人胚胎干细胞向肝细胞样细胞分化过程中的上皮间质转化。它还可阻止有丝分裂并随后通过增殖细胞的凋亡抑制肿瘤生长。
T8537	Tripolin A (3E)-3-[(2,5-二羟基苯基)亚甲基]-1,3-二氢-2H-吲哚-2-酮	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Tripolin A 是一种特异性的非 ATP 竞争性 Aurora A 激酶抑制剂，对Aurora A 和Aurora B 的IC50分别为1.5 μM 和7 μM。
T23426	TC-A 2317 hydrochloride	Others; Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic; Others
	TC-A 2317 hydrochloride 是 Aurora 激酶 A 的抑制剂，Ki 为 1.2 nM，而 Aurora 激酶 B 的 Ki 为 101 nM。 TC-A 2317 hydrochloride 显示出抗肿瘤活性。
T11638	Ilorasertib hydrochloride ABT-348 hydrochloride	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Ilorasertib hydrochloride (ABT-348 hydrochloride) is an ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A (IC50s: 1 nM, 7 nM, 120 nM). It also suppresses RET tyrosine kinase, PDGFRβ, and Flt1 (IC50s: 7 nM, 3 nM, and 32 nM).
T5524	Aurora kinase inhibitor-3 Aurora Kinase Inhibitor III	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Aurora kinase inhibitor-3 (Aurora Kinase Inhibitor III) 是一种有效的，选择性 Aurora A 激酶抑制剂，IC50为 42 nM。
TQ0059	Ilorasertib ABT-348	VEGFR; FLT; c-RET; PDGFR; Aurora Kinase	Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors
	Ilorasertib (ABT-348) 是一种 ATP 竞争性多靶点激酶抑制剂，可抑制 Aurora A、Aurora B 和Aurora C，IC50值为120 nM、7 nM 和1 nM。它还抑制 RET 酪氨酸激酶、PDGFRβ 和 Flt1，IC50为7 nM、3 nM 和 32 nM。
T2509	Tozasertib MK-0457,VX 680	Aurora Kinase; Autophagy	Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Tozasertib (MK-0457) 是一种 Aurora A/B/C 激酶抑制剂，Ki 值分别为 0.6、18和4.6 nM。它显示出对 190 多种不同激酶的选择性。
T6068	MK-5108 VX-689,MK5108	Aurora Kinase; Autophagy	Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic
	MK-5108 (VX-689) 是一种高效且特异性的 Aurora-A 激酶抑制剂，IC50 值为 0.064 nM。
T6126	JNJ-7706621 JNJ 7706621	Apoptosis; CDK; Aurora Kinase	Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic
	JNJ-7706621 是一种aurora kinase 抑制剂，有效抑制CDK1和CDK2，对CDK1，CDK2，aurora-A 和aurora-B 的IC50值分别为 9 nM，3 nM，11 nM 和 15 nM。
T2611	CCT 137690 CCT137690	Apoptosis; Aurora Kinase	Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic
	CCT 137690是一种有口服活性的极光激酶抑制剂，对极光激酶A、B 和C 的IC50值分别为15、25 和19 nM。
T50110	CD532	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	CD532 是一种高效的 Aurora A 激酶抑制剂，IC50 值为 45 nM。CD532 可阻断 Aurora A 激酶活性，驱动 MYCN 降解，可以直接与 AURKA 相互作用并诱导整体构象转变。CD532 可用于研究癌症。
T6315	MLN8054	Casein Kinase; PKA; Src; Aurora Kinase	Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Metabolism; Stem Cells; Tyrosine Kinase/Adaptors
	MLN8054是一种有口服活性的高选择性极光激酶抑制剂，IC50值为4 nM。
T1825	Reversine	Aurora Kinase; Adenosine Receptor; Autophagy	Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic; GPCR/G Protein; Neuroscience
	Reversine 是一种 ATP-竞争性 Aurora kinase 抑制剂，作用于Aurora A、Aurora B 和Aurora C，IC50分别为 400、500 和 400 nM。
T17267	XL228	IGF-1R; Bcr-Abl; Src; Aurora Kinase	Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
	XL228 是一种多靶点酪氨酸激酶抑制剂，对 Bcr-Abl、Aurora A、IGF-1R、Src 和 Lyn 的 IC50 分别为 5、3.1、1.6、6.1和 2 nM。
T34888	TL12-186 TL12 186,TL12186	CDK; Ligand for E3 Ligase	Cell Cycle/Checkpoint; PROTAC
	TL12-186 是一种依赖于 Cereblon 的激酶降解剂，可降解 CDK，BTK，FLT3，Aurora 等激酶。TL12-186 对 CDK2/cyclin A 和 CDK9/cyclin T1 有抑制作用，IC50 分别为 73 和 55 nM。
T2358	ENMD-2076	Apoptosis; VEGFR; FGFR; FLT; c-RET; PDGFR; Src; Aurora Kinase	Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors
	ENMD2076是一种多靶点激酶抑制剂，抑制Aurora A、Flt3、KDR/VEGFR2、Flt4/VEGFR3、FGFR1、FGFR2、Src、PDGFRα的IC50值分别为1.86、14、58.2、15.9、92.7、70.8、20.2 and 56.4 nM。
T2271	SBE13 Hydrochloride SBE 13 hydrochloride,SBE 13 HCl	Apoptosis; PLK; Autophagy	Apoptosis; Autophagy; Cell Cycle/Checkpoint
	SBE13 Hydrochloride (SBE 13 HCl) 是一种选择性的Plk1抑制剂，IC50值为 0.2 nM，对 Plk2 的IC50>66 μM，Plk3的IC50值为875 nM。
T35570	Chiauranib CS2164,西奥罗尼	c-Fms; VEGFR; FLT; PDGFR; c-Kit; Aurora Kinase	Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors
	Chiauranib 是一种针对肿瘤血管生成的多靶点抑制剂，具有强大的抗癌作用。 Chiauranib 有效抑制血管生成相关激酶（VEGFR1、VEGFR2、VEGFR3、PDGFRα 和 c-Kit）、有丝分裂相关激酶 Aurora B 和慢性炎症相关激酶 CSF1R，IC50 值范围为 1-9 nM。
T22288	(1E)-CFI-400437 dihydrochloride CFI-400437 dihydrochloride	PLK	Cell Cycle/Checkpoint
	(1E)-CFI-400437 dihydrochloride (CFI-400437 dihydrochloride) 是一种选择性和有效的 polo 样激酶 4 (PLK4) 抑制剂，IC50为 0.6 nM。它还抑制 Aurora A、 Aurora B、 KDR 和 FLT-3，IC50分别为 0.37、0.21、0.48 和 0.18 μM，具有抗增殖活性。
T4428	CCT241736	FLT; Aurora Kinase	Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors
	CCT241736 是一种口服生物可利用的双重 FLT3/Aurora 激酶抑制剂，还抑制临床相关的 FLT3 耐药突变体，包括 FLT3-ITD 和 FLT3。它是 CCT137690 的高级类似物，是治疗人类恶性肿瘤的临床前开发候选物。
T35328	H-1152 dihydrochloride H-1152 2HCl,H-1152 dihydrochloride	ROCK	Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells
	H-1152 dihydrochloride (H-1152 2HCl) 是 Rho 相关蛋白激酶 (ROCK) 的特异性抑制剂，IC50 为 12 nM，Ki 为 1.6 nM。 H-1152 dihydrochloride 抑制 PKA、PKC、PKG、Aurora A 和 CaMKII，IC50 值分别为 3.03 μM、5.68 μM、0.360 μM、0.745 μM 和 0.180 μM。
T64338	AKI603 AKI 603,AKI-603	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	AKI603 是一种极光激酶 A 抑制剂，IC50值为 12.3 nM。它对白血病细胞具有很强的抗增殖活性，可用于克服白血病中 BCR-ABL-T315I 耐药性突变。
T63773	Aurora kinase inhibitor-8
	Aurora kinase inhibitor-8 是 Aurora 激酶的高度选择性抑制剂。
T68234	BI-831266
	BI-831266 is a potent and selective Aurora kinase B inhibitor.
T10412	Aurora inhibitor 1	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Aurora inhibitor 1 is a potent Aurora inhibitor (IC50: ≤ 4 nM and ≤13 nM for Aurora A and Aurora B kinase).
T62789	Aurora kinase inhibitor-9
	Aurora kinase inhibitor-9 (compound 9d) 是一种有效的 AURKA/B 双极光激酶抑制剂，作用于 Aurora A (IC50: 0.093 μM)、Aurora B (IC50: 0.09 μM)。Aurora kinase inhibitor-9 具有广谱抗增殖活性。
T60783	Aurora/LIM kinase-IN-1
	Aurora/LIM kinase-IN-1 (Compound F114) 是aurora 和lim 激酶的有效双重抑制剂。Aurora/LIM kinase-IN-1 可抑制胶质母细胞瘤的增殖和侵袭，可能用于胶质母细胞瘤和其他癌症相关的药物研发。Aurora 和 LIM 激酶是分别参与肿瘤细胞分裂和细胞运动的激酶。
T24753	SA-16 SA 16
	SA-16 is a potent dual inhibitor of PDK1 and Aurora kinase.
T62647	Aurora A inhibitor 2
	Aurora A inhibitor 2 (Compound 16h) 是一个 Aurora A kinase 的有效抑制剂 (IC50: 21.94 nM)。Aurora A inhibitor 2 能诱导 MDA-MB-231 细胞中的 caspase 依赖性凋亡。
T36801	Binucleine 2
	Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine 2 induces mitotic and cytokinesis defects in Drosophila Kc167 cells. It prevents Drosophila S2 cells from assembling a contractile ring during cell division ...
T68740	NVP-TAC544
	NVP-TAC544 is a novel focal adhesion kinase (FAK) inhibitor, potently blocking kinase activity of FAK along with Aurora A, activated Cdc42-associated kinase 1 (ACK1), Met, insulin receptor (IR), TrkA, and IGF-1R.
T71232	Alisertib sodium hydrate
	Alisertib sodium hydrate is a salt of Alisertib --- an inhibitor of Aurora A kinase with potential antineoplastic activity. Alisertib binds to and inhibits Aurora A kinase, which may result in disruption of the assembly of the mitotic spindle apparatus, disruption of chromosome segregation, and inhibition of cell proliferation.
T39718	Tinengotinib
	Tinengotinib, a novel compound, acts as a potent modulator of protein kinases including Aurora kinase and VEGFR kinase. With its unique properties, Tinengotinib holds promise for investigating diseases marked by abnormalities in these kinases, particularly cancer-related conditions (WO2018108079A1).
T74174	JB170
	JB170 是一种强效且高度特异性的PROTAC 介导的AURORA-A 降解剂 (DC50=28 nM)，通过将 Alisertib 连接至Cereblon 配体 Thalidomide 而形成。JB170 优先结合 AURORA-A (EC50=193 nM) 而不是 AURORA-B (EC50=1.4µM)。JB170 介导的 S 期阻滞是由 AURORA-A 耗竭引起的。JB170 对 AURORA-A 激酶的非催化功能具有很好的抑制能力。
T36932	CD532 hydrochloride
	CD532 hydrochloride is a potent inhibitor of Aurora A kinase, having an IC50 of 45 nM. It not only blocks the activity of Aurora A kinase but also facilitates the degradation of the protein MYCN. Furthermore, CD532 hydrochloride interacts directly with AURKA, inducing a significant conformational change. Its utility in cancer research has been demonstrated [1][2].
T72522	Aurora kinase-IN-1
	Aurora kinase-IN-1 是aurora kinase 的有效抑制剂。Aurora kinase-IN-1 上调 G1 细胞周期抑制蛋白 (包括 p21 和 p27) 以及 G1 进行性细胞周期蛋白 D1 的表达，并下调 G1-to-S 进行性细胞周期蛋白，导致细胞周期停滞在 G1/S 边界。Aurora 激酶-IN-1 还诱导细胞凋亡 (apoptosis）。Aurora 激酶-IN-1 是化疗药物的先导化合物。
T73800	Retreversine
	Retreversine 是 Reversine 的无活性阴性对照。Reversine 是一种 ATP-竞争性的Aurora kinase 抑制剂。
T68332	AKI-001
	AKI-001 is a potent Aurora kinase inhibitor, which exhibits low nanomolar potency against both Aurora A and Aurora B enzymes, excellent cellular potency (IC50 < 100 nM), and good oral bioavailability. Phenotypic cellular assays show that both Aurora A and Aurora B are inhibited at inhibitor concentrations sufficient to block proliferation. Importantly, the cellular activity translates to potent inhibition of tumor growth in vivo. An oral dose of 5 mg/kg QD is well tolerated and results in near s...
T21298	SNS-314 SNS-314 free base,SNS314,SNS 314
	SNS-314, a synthetic small molecule Aurora kinase (AK) inhibitor with potential antineoplastic activity, selectively binds and inhibits AKs A and B, resulting in the inhibition of cell division and proliferation in tumor cells that overexpress AKs.
T61527	GSK2646264
	GSK2646264 (Compound 44) is a highly effective and specific inhibitor of spleen tyrosine kinase (SYK) with a pIC50 of 7.1. In addition to targeting SYK, GSK2646264 also inhibits several other kinases, including LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B, and Aurora A, with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3, respectively. Notably, GSK2646264 demonstrates skin penetrability, reaching both the epidermis and dermis [1].
T38428	Alisertib sodium MLN 8237 sodium
	Alisertib sodium (MLN 8237) is a potent and specific inhibitor (IC50 = 1.2 nM) of Aurora A kinase, an enzyme involved in cell division. By binding to Aurora A kinase, Alisertib sodium disrupts the formation of the mitotic spindle and causes abnormal cell division. At the molecular level, it acts on the AKT/mTOR/AMPK/p38 pathway, leading to the induction of apoptosis and autophagy in leukemic cells. This compound exhibits significant antitumor activity.
T71279	BPR1K653
	BPR1K653 is a potent Aurora kinase inhibitor with potential anticancder activity. BPR1K653 specifically inhibited the activity of Aurora-A and Aurora-B kinase at low nano-molar concentrations in vitro. BPR1K653 was potent in targeting a variety of cancer cell lines regardless of the tissue origin, p53 status, or expression of MDR1. At the cellular level, BPR1K653 induced endo-replication and subsequent apoptosis in both MDR1-negative and MDR1-positive cancer cells. Importantly, it showed potent ...
T82931	Aurora A inhibitor 3	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Aurora A inhibitor3 (Compound 5h) 是一种抑制Aurora-A激酶活性的化合物，IC50为0.78 μM。该化合物同时对MCF-7和MDA-MB-231细胞线表现出细胞毒性，其GI50值分别为0.12 μM和0.63 μM。
T36199	AZD 1152 (hydrochloride)
	AZD 1152 is an orally bioavailable prodrug of AZD 1152-HQPA, a selective inhibitor of Aurora kinase B (IC50= 0.36 nM).1AZD 1152 is converted to AZD 1152-HQPA in plasma. Inhibition of Aurora B results in disruption of spindle checkpoint functions and chromosome alignment, resulting in inhibition of cytokinesis followed by apoptosis.2,3AZD 1152 inhibits tumor xenograft growthin vivo.4,5 1.Mortlock, A.A., Foote, K.M., Heron, N.M., et al.Discovery, synthesis, and in vivo activity of a new class of p...
T78753	Aurora Kinases-IN-4	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Aurora Kinases-IN-4（Compound 11c）是共价ATP竞争型aurora kinaseA抑制剂，具有IC50为1.7 nM。该化合物对SJSA-1、MDA-MB-231、A549和HeLa细胞系的增殖抑制效果显著，其IC50分别为4.27、1.54、3.08和6.99 μM。Aurora Kinases-IN-4适用于三阴性乳腺癌（TNBC）的相关研究。
T14925	Cenisertib AS-703569,R-763	Akt; Bcr-Abl; STAT	Angiogenesis; Cytoskeletal Signaling; JAK/STAT signaling; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors
	Cenisertib 是一种有效的 ATP 竞争性的多激酶抑制剂，对 Aurora-kinase-A/B，ABL1，AKT，STAT5, FLT3 的活性具有抑制作用，对FER 及其同源物的激酶也显示出抑制作用。Cenisertib 通过抑制肿瘤肥大细胞 (MC) 中几种不同分子靶标的活性抑制其生长，也抑制异种移植模型中胰腺癌，乳腺癌，结肠癌，卵巢癌和肺癌以及白血病的肿瘤生长。
T69296	PHA-680626
	PHA-680626 is a potent and selective PLK inhibitor. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases. PHA-680626 inhibits Plk1 (IC50 = 0.53 μM), Plk2 (IC50 = 0.07 μM) and Plk3 (IC50 = 1.61 μM).
T61061	JH295 hydrate
	JH295 hydrate 通过 Cys22 烷基化从而抑制细胞Nek2，它是有效的，不可逆和选择性的NIMA 相关激酶 2 (Nek2)抑制剂 (IC50 = 770 nM)。JH295 hydrate 对有丝分裂激酶 Cdk1，Aurora B 或 Plk1 不具有活性，不干扰双极纺锤体组件或纺锤体组件检查点。

化合物

Aurora kinase inhibitor-2

Cat.No: T9040

Synonym: IUN-70219,Aurora Kinase Inhibitor II

Target: Aurora Kinase

Cat.No: T6767

Synonym: Aurora A Inhibitor I

Target: Apoptosis, Aurora Kinase

Phthalazinone pyrazole

Cat.No: T21981

Target: Aurora Kinase

Cat.No: T8537

Synonym: (3E)-3-[(2,5-二羟基苯基)亚甲基]-1,3-二氢-2H-吲哚-2-酮

Target: Aurora Kinase

TC-A 2317 hydrochloride

Cat.No: T23426

Target: Others, Aurora Kinase

Ilorasertib hydrochloride

Cat.No: T11638

Synonym: ABT-348 hydrochloride

Target: Aurora Kinase

Aurora kinase inhibitor-3

Cat.No: T5524

Synonym: Aurora Kinase Inhibitor III

Target: Aurora Kinase

Cat.No: TQ0059

Synonym: ABT-348

Target: VEGFR, FLT, c-RET, PDGFR, Aurora Kinase

Cat.No: T2509

Synonym: MK-0457,VX 680

Target: Aurora Kinase, Autophagy

Cat.No: T6068

Synonym: VX-689,MK5108

Target: Aurora Kinase, Autophagy

Cat.No: T6126

Synonym: JNJ 7706621

Target: Apoptosis, CDK, Aurora Kinase

Cat.No: T2611

Synonym: CCT137690

Target: Apoptosis, Aurora Kinase

Cat.No: T50110

Target: Aurora Kinase

Cat.No: T6315

Target: Casein Kinase, PKA, Src, Aurora Kinase

Cat.No: T1825

Target: Aurora Kinase, Adenosine Receptor, Autophagy

Cat.No: T17267

Target: IGF-1R, Bcr-Abl, Src, Aurora Kinase

Cat.No: T34888

Synonym: TL12 186,TL12186

Target: CDK, Ligand for E3 Ligase

Cat.No: T2358

Target: Apoptosis, VEGFR, FGFR, FLT, c-RET, PDGFR, Src, Aurora Kinase

SBE13 Hydrochloride

Cat.No: T2271

Synonym: SBE 13 hydrochloride,SBE 13 HCl

Target: Apoptosis, PLK, Autophagy

Cat.No: T35570

Synonym: CS2164,西奥罗尼

Target: c-Fms, VEGFR, FLT, PDGFR, c-Kit, Aurora Kinase

(1E)-CFI-400437 dihydrochloride

Cat.No: T22288

Synonym: CFI-400437 dihydrochloride

Target: PLK

Cat.No: T4428

Target: FLT, Aurora Kinase

H-1152 dihydrochloride

Cat.No: T35328

Synonym: H-1152 2HCl,H-1152 dihydrochloride

Target: ROCK

Cat.No: T64338

Synonym: AKI 603,AKI-603

Target: Aurora Kinase

Aurora kinase inhibitor-8

Cat.No: T63773

Cat.No: T68234

Aurora inhibitor 1

Cat.No: T10412

Target: Aurora Kinase

Aurora kinase inhibitor-9

Cat.No: T62789

Aurora/LIM kinase-IN-1

Cat.No: T60783

Cat.No: T24753

Synonym: SA 16

Aurora A inhibitor 2

Cat.No: T62647

Cat.No: T36801

Cat.No: T68740

Alisertib sodium hydrate

Cat.No: T71232

Cat.No: T39718

Cat.No: T74174

CD532 hydrochloride

Cat.No: T36932

Aurora kinase-IN-1

Cat.No: T72522

Cat.No: T73800

Cat.No: T68332

Cat.No: T21298

Synonym: SNS-314 free base,SNS314,SNS 314

Cat.No: T61527

Alisertib sodium

Cat.No: T38428

Synonym: MLN 8237 sodium

Cat.No: T71279

Aurora A inhibitor 3

Cat.No: T82931

Target: Aurora Kinase

AZD 1152 (hydrochloride)

Cat.No: T36199

Aurora Kinases-IN-4

Cat.No: T78753

Target: Aurora Kinase

Cat.No: T14925

Synonym: AS-703569,R-763

Target: Akt, Bcr-Abl, STAT

Cat.No: T69296

Cat.No: T61061

Cat. No.	Product Name	Target	Signaling Pathways
TN3834	Derrone	Antifection	Microbiology/Virology
	Derrone may be interesting antimicrobial agents to be used against infectious diseases caused by many pathogens. It is also a novel Aurora kinase inhibitor, it can significantly inhibit the formation and growth of MCF7 tumor spheroids.

天然产物

Cat.No: TN3834

Target: Antifection

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼